00Read later0Read MoreSELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateBusiness - Latest - Google News·3 days ago#yXvIcVhQ#world#news#ir#million#sellas+5 more🧰Tag tools✨Add tag- Topline Primary Endpoint Results of the Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia Following the 80th Event to Report this Month - - 40 Patients Enrolled in Phase 2 Trial of SLS009 in Newly Diagnosed First-Line AML;… Read more15s